238 filings
8-K
CARM
Carisma Therapeutics Inc
10 Apr 24
Other Events
8:00am
8-K
CARM
Carisma Therapeutics Inc
1 Apr 24
Carisma Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
8:41am
8-K
CARM
Carisma Therapeutics Inc
9 Nov 23
Carisma Therapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights
7:42am
8-K
CARM
Carisma Therapeutics Inc
1 Sep 23
Carisma Announces Latest Data from Phase 1 Clinical Trial of CT-0508 at 8th Annual CAR-TCR Summit
9:05am
8-K
CARM
Carisma Therapeutics Inc
10 Aug 23
Carisma Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights
7:36am
8-K
75q1kr5tjzzlnr9ik
9 Jun 23
Departure of Directors or Certain Officers
4:17pm
8-K
r0ozzq83
12 May 23
Entry into a Material Definitive Agreement
5:05pm
8-K
6rec i31wvvgsbbp5746
12 May 23
Carisma Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Highlights
4:47pm
8-K/A
6j8h0e 5fomw7q
4 Apr 23
Results of Operations and Financial Condition
8:40am
8-K
zwlum08y
7 Mar 23
Carisma Therapeutics Closes Merger with Sesen Bio
7:00pm
8-K
bx8hjwlkd0cfvji294
6 Mar 23
Other Events
12:34pm
8-K
odq8ao6ditx
2 Mar 23
Material Modifications to Rights of Security Holders
12:06pm
8-K
krzkfatoyln y3srta
28 Feb 23
Results of Operations and Financial Condition
8:00am
8-K
8c2 wb7u4
27 Feb 23
Other Events
8:01am
8-K
ctnuslzqtyo g3kr6ax
14 Feb 23
Sesen Bio and Carisma Therapeutics Announce Increased Special Cash Dividend and Stockholder Support for Pending Merger
9:02am
8-K
mn3e9qmp207k4w0
7 Feb 23
Other Events
4:29pm
8-K
xd9bxey3o 4soaroiqs
2 Feb 23
Sesen Bio Files Investor Presentation in Connection with Pending Carisma Therapeutics Merger
4:44pm
8-K
2enkqc05
1 Feb 23
Other Events
8:00am
8-K
qpzjlx
31 Jan 23
Other Events
4:02pm
8-K
cg8uiiv
30 Jan 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8:01am